Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Scaled Net Operating Assets : 0.70 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Laboratorios Farmaceuticos Rovi's operating assets for the quarter that ended in Dec. 2023 was €774.6 Mil. Laboratorios Farmaceuticos Rovi's operating liabilities for the quarter that ended in Dec. 2023 was €191.0 Mil. Laboratorios Farmaceuticos Rovi's Total Assets for the quarter that ended in Sep. 2023 was €830.7 Mil. Therefore, Laboratorios Farmaceuticos Rovi's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.70.

Laboratorios Farmaceuticos Rovi Scaled Net Operating Assets Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Scaled Net Operating Assets Chart

Laboratorios Farmaceuticos Rovi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.84

0.77

0.78

0.64

0.66

Laboratorios Farmaceuticos Rovi Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.61	0.57	0.49	0.62	0.70

Competitive Comparison of Laboratorios Farmaceuticos Rovi's Scaled Net Operating Assets

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorios Farmaceuticos Rovi's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Scaled Net Operating Assets falls into.

Laboratorios Farmaceuticos Rovi Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Laboratorios Farmaceuticos Rovi's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(774.562	-	190.963)	/	878.703
=	0.66

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	799.884	-	25.322
=	774.562

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	256.39	-	52.242	-	13.185
=	190.963

Laboratorios Farmaceuticos Rovi's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Sep. 2023 )
=	(774.562	-	190.963)	/	830.725
=	0.70

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	799.884	-	25.322
=	774.562

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	256.39	-	52.242	-	13.185
=	190.963

Laboratorios Farmaceuticos Rovi Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

ROVI:Mexico ROVIe:UK 41L:Germany

Address

Julian Camarillo, 35, Madrid, ESP, 28037

Website

https://www.rovi.es

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.